{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:13:08Z","timestamp":1771589588429,"version":"3.50.1"},"reference-count":22,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>\n            Infections caused by antibiotic-resistant Gram-negative bacteria expressing extended-spectrum \u03b2-lactamases and carbapenemases are a growing global problem resulting in increased morbidity and mortality with limited treatment options. LYS228 is a novel intravenous monobactam antibiotic targeting penicillin binding protein 3 with potent activity against\n            <jats:named-content content-type=\"genus-species\">Enterobacteriaceae<\/jats:named-content>\n            , including multidrug-resistant clinical isolates expressing serine and metallo-\u03b2-lactamases.\n          <\/jats:p>","DOI":"10.1128\/aac.02592-18","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T12:24:35Z","timestamp":1556886275000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["A First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers"],"prefix":"10.1128","volume":"63","author":[{"given":"Megan","family":"Osborn","sequence":"first","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Stachulski","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Sun","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanne","family":"Blais","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Emeryville, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Venishetty","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Hyderabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Raccuglia","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kankam","sequence":"additional","affiliation":[{"name":"Vince and Associates Clinical Research, Overland Park, Kansas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Colvin","sequence":"additional","affiliation":[{"name":"Bluebird Bio, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia","family":"Segal","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-3"},{"key":"e_1_3_1_3_2","volume-title":"Antimicrobial resistance: biggest threats","author":"Centers for Disease Control and Prevention","year":"2016","unstructured":"Centers for Disease Control and Prevention. 2016. Antimicrobial resistance: biggest threats. Centers for Disease Control and Prevention, Atlanta, GA."},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1054-1"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/650482"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir611"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12091"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.01.006"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01200-18"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky478"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02214-18"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00552-18"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.03.003"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03938-14"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02379-15"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-10-845"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00568-16"},{"key":"e_1_3_1_18_2","volume-title":"Injection, USP ID 41462","author":"The Medicines Company","year":"2017","unstructured":"The Medicines Company. 2017. Vabomere prescribing information. Injection, USP ID 41462. The Medicines Company, Parsippany, NJ."},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90206-2"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12107"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1086\/590064"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.Supplement_2.S266"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02228-17"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02592-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02592-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:34:32Z","timestamp":1645479272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02592-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1128\/AAC.02592-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.02592-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"2018-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02592-18"}}